- Page 1: Women drug abuse in Europe:gender i
- Page 5 and 6: © IREFREA & European CommissionI.S
- Page 7 and 8: ORGANIZATIONS AND NATIONAL RESEARCH
- Page 10 and 11: INDEXPagePreface(by P. Stocco, A. C
- Page 12 and 13: PREFACEThis book presents a series
- Page 14 and 15: female exposes herself to the risk
- Page 16 and 17: DRUG ADDICTION AND MATERNITYActive
- Page 18: devaluation of the daughter is ther
- Page 21 and 22: Europe, leads to the situation that
- Page 23 and 24: Accordingly, the study was construc
- Page 25 and 26: -Dimension of maternity-Legal dimen
- Page 28 and 29: CHAPTER 1WOMEN AND DRUG ABUSE. GENE
- Page 30 and 31: Thom 1995, Nelson-Zlupko et al, Ett
- Page 32 and 33: ole of double dependency so typical
- Page 34 and 35: problem. The use of benzodiazepines
- Page 36 and 37: THERAPYThe effectiveness of the dif
- Page 38: - Diagnostic criteria and treatment
- Page 41 and 42: The sphere of sexuality does not ap
- Page 43 and 44: ehaviour of intravenous drug addict
- Page 46 and 47: CHAPTER 3GENDER IDENTITY AND DRUG A
- Page 48 and 49: of female drug addiction with respe
- Page 50 and 51: It has also been noticed that it is
- Page 52:
even if this should not be neglecte
- Page 55 and 56:
The analysis of specific experience
- Page 57 and 58:
diploma and vice-versa a high perce
- Page 59 and 60:
(11.7%), or due to indifference (10
- Page 61 and 62:
drugs (9.1%). The same two typologi
- Page 63 and 64:
month (overall with ample variation
- Page 65 and 66:
out that the female sex is characte
- Page 67 and 68:
the school as an institution with t
- Page 70 and 71:
BEST PRACTICES(*)The aim of this pa
- Page 72 and 73:
Intervention methods:Network struct
- Page 74 and 75:
SPAIN1. Treatment centre for drug a
- Page 76 and 77:
The PIS has four double rooms, two
- Page 78 and 79:
6. Comunidad terapéutica femeninaL
- Page 80 and 81:
Network contacts:Close co-operation
- Page 82 and 83:
For whom:Women with babies.Interven
- Page 84 and 85:
10. Programme for women with proble
- Page 86 and 87:
tel.+49 30 6921782fax.+49 30 695061
- Page 88 and 89:
2. Programme for sero-positive drug
- Page 90 and 91:
Team:7 social operators of which 2
- Page 92:
Therapeutic approach: individual an
- Page 96 and 97:
VADEMECUMOne of the main aims of th
- Page 98 and 99:
An MMP is seen as contra-indicated
- Page 100 and 101:
11) Improving the activity of infor
- Page 102:
34) During pregnancy addicted women
- Page 106 and 107:
IREFREA:Drug-addiction and gender i
- Page 108 and 109:
9) If no, why? (multiple choices)1:
- Page 110 and 111:
19) What was the result? (multiple
- Page 112 and 113:
• Could you explain the reason of
- Page 114 and 115:
38) If your partner used to take dr
- Page 116 and 117:
5: danger of diseases ❒ 48.56: ba
- Page 118 and 119:
60) Present relationship: (only 1 a
- Page 120 and 121:
75) Which were your worries? (multi
- Page 122 and 123:
6: drug-addiction ❒ 86.67: prejud
- Page 124 and 125:
• How did doctors and the staff b
- Page 126 and 127:
LEGAL DIMENSION113) Have you actual
- Page 128 and 129:
• Have you ever felt discriminate
- Page 130 and 131:
137) How old were you when you real
- Page 132 and 133:
BIBLIOGRAPHYAgnoletto V., Cesarani
- Page 134 and 135:
Booth, R. et al. (1991) “Intraven
- Page 136 and 137:
Cuskey, W (1982) “Female Addictio
- Page 138 and 139:
Gatti U., Marugo M. I., Malfatti D.
- Page 140 and 141:
Lejeun-E C. (1997) “Prise en char
- Page 142 and 143:
Modonutti G.B. (1996) “ Modelli d
- Page 144 and 145:
Ravenna M. (1993) Adolescenti e dro
- Page 146 and 147:
Swift, W., Copeland, J. Y Hall, W.
- Page 150:
I R E F R E AIREFREA is a european